إعلان مُمول
DMCA
FDA nod for Novavax Covid vax, with stricter new conditions
The FDA has approved the Novavax Covid-19 vaccine, but with restrictions, limiting its use to older adults and those over 12 with high-risk medical conditions. This decision follows debates among CDC advisors about targeting Covid shots to the most vulnerable. The new limitations signal a potentially more restrictive approach from the FDA, influenced by skepticism towards vaccines.
English
नेपाली
हिन्दी
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
French
অসমীয়া
বাংলা